Literature DB >> 20468075

Further investigation of the association between rs7341475 and rs17746501 and schizophrenia.

Eyal Ben-David1, Sagiv Shifman.   

Abstract

Genome-wide association studies (GWAS) with small sample size have had limited statistical power in identifying schizophrenia susceptibility genes. This is exemplified by the fact that one of the most convincing associations was detected only after meta-analyses of three different GWAS. Here we used meta-analysis to study the association of two single-nucleotide polymorphisms (SNPs) (rs7341475 and rs17746501) previously indicated to be associated with schizophrenia by a GWAS of Ashkenazi Jews (AJ). In the initial report, rs7341475 was associated only in women, while rs17746501 was associated in both men and women. We collected genotyping results of samples published in four GWAS for the two SNPs, additional to results from AJ. We used the Mantel-Haenszel method to combine the data of the different samples. For both SNPs, the results of the meta-analysis of all samples, including the initial report, did not reach a genome-wide significance level. However, the association between rs7341475 and schizophrenia in women, after excluding the data from AJ, was significant (P = 9.0 x 10(-3)), with a calculated odds ratio (OR) of 1.11, much smaller than the original result. Association between rs17746501 and schizophrenia was significant in four of the new samples, showing evidence for heterogeneity and very small effect when tested across all samples (P = 0.016, OR = 1.06). These findings suggest that the two SNPs might have a small effect on schizophrenia risk and suggest that meta-analyses of very large samples are needed to adequately study the contribution of common variants to schizophrenia susceptibility. (c) 2010 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20468075     DOI: 10.1002/ajmg.b.31093

Source DB:  PubMed          Journal:  Am J Med Genet B Neuropsychiatr Genet        ISSN: 1552-4841            Impact factor:   3.568


  7 in total

Review 1.  Extracellular matrix abnormalities in schizophrenia.

Authors:  Sabina Berretta
Journal:  Neuropharmacology       Date:  2011-08-16       Impact factor: 5.250

2.  RELN rs7341475 and schizophrenia risk: confusing, yet somehow intriguing.

Authors:  Heike Tost; Daniel R Weinberger
Journal:  Biol Psychiatry       Date:  2011-03-01       Impact factor: 13.382

Review 3.  The involvement of Reelin in neurodevelopmental disorders.

Authors:  Timothy D Folsom; S Hossein Fatemi
Journal:  Neuropharmacology       Date:  2012-09-07       Impact factor: 5.250

4.  The genetic variation of RELN expression in schizophrenia and bipolar disorder.

Authors:  Galit Ovadia; Sagiv Shifman
Journal:  PLoS One       Date:  2011-05-16       Impact factor: 3.240

5.  Association of the type 2 diabetes mellitus susceptibility gene, TCF7L2, with schizophrenia in an Arab-Israeli family sample.

Authors:  Anna Alkelai; Lior Greenbaum; Sara Lupoli; Yoav Kohn; Kyra Sarner-Kanyas; Edna Ben-Asher; Doron Lancet; Fabio Macciardi; Bernard Lerer
Journal:  PLoS One       Date:  2012-01-11       Impact factor: 3.240

Review 6.  Reelin and Neuropsychiatric Disorders.

Authors:  Kazuhiro Ishii; Ken-Ichiro Kubo; Kazunori Nakajima
Journal:  Front Cell Neurosci       Date:  2016-10-18       Impact factor: 5.505

Review 7.  Wnt/β-catenin signaling in brain development and mental disorders: keeping TCF7L2 in mind.

Authors:  Joanna Bem; Nikola Brożko; Chaitali Chakraborty; Marcin A Lipiec; Kamil Koziński; Andrzej Nagalski; Łukasz M Szewczyk; Marta B Wiśniewska
Journal:  FEBS Lett       Date:  2019-06-30       Impact factor: 4.124

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.